-
2024-518296-56-00
5
2025-09-29
Crohn’s Disease
-
2024-518399-29-00
5
2024-12-27
Testicular cancer
-
2024-514135-17-00
5
2024-11-28
Immunoglobulin A Nephropathy
-
2023-505000-27-01
4
2023-12-29
newly diagnosed pediatric FLT3-ITD positive and NPM1 wild-type AML
-
2023-505277-32-00
5
2023-01-26
Diffuse Large B-Cell Lymphoma (DLBCL)
-
2022-502503-30-00
5
2022-12-15
Acute lymphoblastic leukemia
-
2022-500966-82-00
5
2020-03-11
Resectable locally advanced squamous cell carcinoma (SCC) of the esoph
-
2025-524872-51-00
6
2026-05-25
Rheumatoid arthritis-associated interstitial lung disease (RA-ILD)
-
2025-524022-18-00
4
2026-05-22
Multiple myeloma
-
2025-522674-36-00
5
2026-03-24
Metabolic Dysfunction-Associated Steatotic Liver Disease
-
2025-521620-29-01
4
2026-01-26
Atopic Dermatitis
-
2025-520825-19-00
5
2025-12-16
IgAN is Primary Immunoglobulin A Nephropathy (IgAN) (also known as
Ber
-
2025-521382-27-00
10
2025-12-04
Moderately to Severely Active Crohn's Disease
-
2025-521381-10-00
5
2025-12-03
Moderately to Severely Active Ulcerative Colitis
-
2025-521391-58-00
4
2025-11-28
Asthma
-
2024-519871-24-00
10
2025-11-11
Breast cancer
-
2024-519917-72-00
5
2025-10-29
Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with C
-
2024-519495-83-00
4
2025-10-28
Digestive system diseases
-
2024-519670-39-00
3
2025-10-13
Healthy participants
-
2024-516652-18-00
5
2025-10-10
Atherosclerotic cardiovascular disease (ASCVD) and obesity or overweig
-
2024-519827-16-00
5
2025-09-30
Newly Diagnosed Transplant Ineligible Multiple Myeloma Patients
-
2024-519667-18-00
6
2025-08-21
Pancreatic conditions requiring pancreaticoduodenectomy, such as pancr
-
2024-515106-30-00
9
2025-08-06
Type 1 diabetes
-
2024-518218-24-00
4
2025-07-17
Prolonged grief disorder